These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27563647)

  • 1. Overview of advances in cancer immunotherapy.
    Kotoula V; Fountzilas G
    Ann Transl Med; 2016 Jul; 4(14):260. PubMed ID: 27563647
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in the field of anti-cancer immunotherapy.
    Neves H; Kwok HF
    BBA Clin; 2015 Jun; 3():280-8. PubMed ID: 26673349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Profiling of Cancer Patients Treated with Immunotherapy: Advances and Challenges.
    Pilla L; Maccalli C
    Biomedicines; 2018 Jul; 6(3):. PubMed ID: 30004433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway.
    Wakabayashi G; Lee YC; Luh F; Kuo CN; Chang WC; Yen Y
    J Biomed Sci; 2019 Dec; 26(1):96. PubMed ID: 31801525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunotherapy in ovarian cancer].
    Weinberger V; Minár L
    Ceska Gynekol; 2012 Apr; 77(2):145-52. PubMed ID: 22702073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translating Science into Survival: Report on the Third International Cancer Immunotherapy Conference.
    Diken M; Chu KK; Brodsky AN
    Cancer Immunol Res; 2018 Jan; 6(1):10-13. PubMed ID: 29298782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updates on immunotherapy for colorectal cancer.
    Kalyan A; Kircher S; Shah H; Mulcahy M; Benson A
    J Gastrointest Oncol; 2018 Feb; 9(1):160-169. PubMed ID: 29564182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing cancer immunotherapy research in Iran: adoptive cell therapy on the horizon.
    Khatami F; Torabi-Rahvar M; Kiani J; Naderi M; Ahmadbeigi N
    Cytotherapy; 2018 Oct; 20(10):1227-1237. PubMed ID: 30266521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in specific immunotherapy for prostate cancer.
    Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
    Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new hope: the immunotherapy in small cell lung cancer.
    Li Q; Yuan D; Ma C; Liu Y; Ma L; Lv T; Song Y
    Neoplasma; 2016; 63(3):342-50. PubMed ID: 26925794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the challenges and recent advances in cancer immunotherapy.
    Baronzio G; Parmar G; Shubina IZh; Cassutti V; Giuli S; Ballerini M; Kiselevsky M
    Immunotargets Ther; 2013; 2():39-49. PubMed ID: 27471687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in nanomaterial-based synergistic combination cancer immunotherapy.
    Sang W; Zhang Z; Dai Y; Chen X
    Chem Soc Rev; 2019 Jul; 48(14):3771-3810. PubMed ID: 31165801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent advances and future challenges in cancer immunotherapy].
    Okuyama N; Tamada K; Tamura H
    Rinsho Ketsueki; 2016; 57(11):2388-2395. PubMed ID: 27941290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-viral gene delivery for cancer immunotherapy.
    Wang W; Saeed M; Zhou Y; Yang L; Wang D; Yu H
    J Gene Med; 2019 Jul; 21(7):e3092. PubMed ID: 30991453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in hymenoptera venom immunotherapy.
    Bilò BM; Bonifazi F
    Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):567-73. PubMed ID: 17989536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects and progress of immunotherapy for bladder cancer.
    Boegemann M; Aydin AM; Bagrodia A; Krabbe LM
    Expert Opin Biol Ther; 2017 Nov; 17(11):1417-1431. PubMed ID: 28832261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Believer's Overview of Cancer Immunosurveillance and Immunotherapy.
    Finn OJ
    J Immunol; 2018 Jan; 200(2):385-391. PubMed ID: 29311379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lost in the crowd: identifying targetable MHC class I neoepitopes for cancer immunotherapy.
    Wilson EA; Anderson KS
    Expert Rev Proteomics; 2018 Dec; 15(12):1065-1077. PubMed ID: 30408427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in Polymeric Nanomedicines for Cancer Immunotherapy.
    Lee ES; Shin JM; Son S; Ko H; Um W; Song SH; Lee JA; Park JH
    Adv Healthc Mater; 2019 Feb; 8(4):e1801320. PubMed ID: 30666822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy for Melanoma.
    Albittar AA; Alhalabi O; Glitza Oliva IC
    Adv Exp Med Biol; 2020; 1244():51-68. PubMed ID: 32301010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.